Moderna Rises 7% On Agreement To Supply Addl. 50 Million Doses Of Covid-19 Vaccine To Japan

Shares of Moderna, Inc. (MRNA) are up more than 7% in the morning trade on Tuesday.

The company today said the Ministry of Health, Labour and Welfare of Japan (MHLW) and Takeda Pharmaceutical Co. (TAK) have agreed to purchase an additional 50 million doses of Moderna's COVID-19 vaccine and its updated variant booster vaccine candidate, if authorized, to begin delivery in 2022.

This new supply agreement adds to the prior agreement for 50 million doses.

MRNA touched a new high of $338.65 this morning.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Follow RTT